Hominin lower second premolar morphology: evolutionary inferences through geometric morphometric analysis M Martinón-Torres, M Bastir, JMB De Castro, A Gómez, S Sarmiento, ... Journal of human evolution 50 (5), 523-533, 2006 | 208 | 2006 |
Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer C Frías, C García-Aranda, C De Juan, A Morán, P Ortega, A Gómez, ... Lung cancer 60 (3), 416-425, 2008 | 124 | 2008 |
Catamenial pneumothorax caused by diaphragmatic endometriosis S Blanco, F Hernando, A Gomez, MJ Gonzalez, AJ Torres, JL Balibrea The Journal of Thoracic and Cardiovascular Surgery 116 (1), 179-180, 1998 | 108 | 1998 |
Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer M Díez, A Torres, ML Maestro, MD Ortega, A Gomez, M Pollan, JA Lopez, ... British journal of cancer 73 (10), 1248-1254, 1996 | 107 | 1996 |
Clinical value of p53, c‐erbB‐2, CEA and CA125 regarding relapse, metastasis and death in resectable non‐small cell lung cancer M Pollán, G Varela, A Torres, M de la Torre, MD Ludeña, MD Ortega, ... International journal of cancer 107 (5), 781-790, 2003 | 101 | 2003 |
Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer P Iniesta, A Morán, C De Juan, A Gómez, F Hernando, C García-Aranda, ... Oncology reports 17 (1), 217-223, 2007 | 100 | 2007 |
Frequency, risk factors, clinical characteristics, and outcomes of spontaneous pneumothorax in patients with coronavirus disease 2019: a case-control, emergency medicine-based … O Miro, P Llorens, S Jimenez, P Pinera, G Burillo-Putze, A Martin, ... Chest 159 (3), 1241-1255, 2021 | 98 | 2021 |
Dysregulation of β-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma AM Lowy, C Fenoglio-Preiser, OJ Kim, J Kordich, A Gomez, J Knight, ... Annals of surgical oncology 10, 284-290, 2003 | 93 | 2003 |
Exercise training and cytokines in breast cancer survivors AM Gómez, C Martínez, C Fiuza-Luces, F Herrero, M Pérez, L Madero, ... International journal of sports medicine, 461-467, 2011 | 88 | 2011 |
Phase III study of first-line XELOX plus bevacizumab (BEV) for 6 cycles followed by XELOX plus BEV or single-agent (s/a) BEV as maintenance therapy in patients (pts) with … J Tabernero, E Aranda, A Gomez, B Massuti, J Sastre, A Abad, ... Journal of Clinical Oncology 28 (15_suppl), 3501-3501, 2010 | 72 | 2010 |
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: phase II … E Aranda, P García-Alfonso, M Benavides, AS Ruiz, C Guillén-Ponce, ... European journal of cancer 101, 263-272, 2018 | 69 | 2018 |
Diccionario LID Marketing directo e interactivo J Van Nispen, M Fraguas, D Álvarez, A Gómez, JC Alcaide, C Almarza, ... Madrid, España: LID Editorial, 2012 | 64 | 2012 |
Video-assisted thoracoscopic lung biopsy in the diagnosis of interstitial lung disease: a prospective, multi-center study in 224 patients JJ Fibla, L Molins, A Blanco, Í Royo, PM Vallina, N Martínez, SG Barajas, ... Archivos de Bronconeumología (English Edition) 48 (3), 81-85, 2012 | 59 | 2012 |
La importancia del gestor deportivo en el municipio AMG Tafalla, JAM Sancho, AM Gómez Inde, 2005 | 57 | 2005 |
Prognostic significance of serum ca 125 antigen assay in patients with non‐small cell lung cancer M Diez, J Granell, A Torres, A Gomez, JL Balibrea, M Pollán, D Ortega, ... Cancer 73 (5), 1368-1376, 1994 | 57 | 1994 |
Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status T Fernández-Marcelo, A Gómez, I Pascua, C de Juan, J Head, ... Journal of Experimental & Clinical Cancer Research 34, 1-7, 2015 | 56 | 2015 |
Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients JL Casado, C Santiuste, M Vazquez, S Bañón, M Rosillo, A Gomez, ... Aids 30 (9), 1423-1431, 2016 | 53 | 2016 |
Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue M Diez, M Pollan, M Maestro, A Torres, D Ortega, A Gomez, A Sanchez, ... British journal of cancer 75 (5), 684-689, 1997 | 53 | 1997 |
Treating KRAS-mutant NSCLC: latest evidence and clinical consequences P Garrido, ME Olmedo, A Gómez, L Paz Ares, F López-Ríos, ... Therapeutic Advances in Medical Oncology 9 (9), 589-597, 2017 | 48 | 2017 |
Chemokines and relapses in childhood acute lymphoblastic leukemia: a role in migration and in resistance to antileukemic drugs AM Gómez, C Martínez, M González, A Luque, GJ Melen, J Martínez, ... Blood Cells, Molecules, and Diseases 55 (3), 220-227, 2015 | 45 | 2015 |